Hemodynamic Impact of Cytosorb and CKRT in Children With Septic Shock
PedCyto
Impact of Cytosorb and CKRT on Hemodynamics in Pediatric Patients With Septic Shock: the PedCyto Study
1 other identifier
interventional
17
1 country
1
Brief Summary
Impact of the hemoadsorption with Cytosorb on hemodynamic in pediatric patients with septic shock: a prospectic pediatric pilot study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
December 4, 2022
CompletedFirst Posted
Study publicly available on registry
December 21, 2022
CompletedDecember 21, 2022
December 1, 2022
2.1 years
December 4, 2022
December 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vasopressors and inotropes reduction
Proportion of patients who achieved a significant reduction in vasopressors or inotropes dose from baseline to the end of treatment.
96 hours
Secondary Outcomes (1)
Changes in hemodynamic parameters
96 hours
Other Outcomes (4)
Organ dysfunction change
96 hours
Biomarkers of infection change
96 hours
Perfusion indexes change
96 hours
- +1 more other outcomes
Study Arms (1)
Hemoperfusion and CKRT in pediatric septic shock
EXPERIMENTALHemoperfusion with Cytosorb in combination with CKRT
Interventions
Cytosorb cartridge It is composed of polystyrene divinylbenzene and polyvinylpyrrolidone copolymers and targets molecules in the 5-50 kDa range, which includes the molecular mass of several cytokines
Eligibility Criteria
You may qualify if:
- Children weighing ≥ 10 kg
- Septic shock as defined by the International Pediatric Consensus Conference
- Need for Continuous Renal Replacement Therapy (CRRT) = acute kidney injury defined by the KDIGO criteria (16) AND/OR fluid overload ≥ 10%
You may not qualify if:
- Refused consensus by parents
- Concomitant use of other extracorporeal blood purification techniques.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gabriella Bottari
Rome, 00151, Italy
Related Publications (1)
Bottari G, Guzzo I, Cappoli A, Labbadia R, Perdichizzi S, Serpe C, Creteur J, Cecchetti C, Taccone FS. Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study. Front Pediatr. 2023 Sep 15;11:1259384. doi: 10.3389/fped.2023.1259384. eCollection 2023.
PMID: 37780052DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor, Principal Investigator, Pediatric Intensivist
Study Record Dates
First Submitted
December 4, 2022
First Posted
December 21, 2022
Study Start
September 1, 2019
Primary Completion
October 1, 2021
Study Completion
October 1, 2021
Last Updated
December 21, 2022
Record last verified: 2022-12